Across TCGA pan-cancer cohorts, MIR520D Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated MIR520D data layer compared with 4 for mass-spec protein.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher MIR520D Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR520D expression acts as an unfavorable survival marker.

OV are the cancer types where MIR520D Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Median	II,III,IV	0.208	0.541	.018	18	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: MIR520D tumor-vs-normal RNA expression · all MIR520D data types